Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients

Clinical trial NCT00622089 · TERMINATED

Trial details

NCT number: NCT00622089
Sponsor: DiObex
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2008-01-01
Primary completion: 2008-12-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.